17.1 C
Harare
Sunday, January 11, 2026
HomeHealthIndian scientists discover natural compound that accelerates diabetic wound

Indian scientists discover natural compound that accelerates diabetic wound

Date:

Related stories

Prof. Gift Mugano Dumps Chamisa, Repositions Himself

HARARE – Zimbabwean economics professor Gift Mugano has publicly...

UK visa rule changes spark alarm among Zimbabwean care workers

More than 21 000 Zimbabweans have been granted Health...

NSSA loses bid to cancel US$10 million software deal

The National Social Security Authority (NSSA) has lost a...

New term, new rules: How Govt will track your child’s school

The opening of the 2026 first term will be...

Potatoes rising demand presents opportunities

The New Year brings a wealth of opportunities and...

Ramaphosa issues warning to Trump, US and Israel over ‘bullying’ and regime-change

MORULENG – South African President Cyril Ramaphosa has issued...

Salah scores and Egypt eliminates Ivory Coast to join Nigeria in Africa Cup semifinals

RABAT, Morocco — Mohamed Salah scored and Egypt eliminated...

RESEARCHERS at Indian Nagaland University have discovered a naturally occurring plant compound, Sinapic acid, that significantly accelerates wound healing in diabetic conditions. This is reported by ANI, a partner of TV BRICS.

The breakthrough offers a promising step towards developing safe, affordable, and natural treatments for one of diabetes’ most persistent complications – delayed wound recovery.

This is the first global study to demonstrate that Sinapic acid, when taken orally, enhances diabetic wound healing in preclinical models. The compound works by activating the SIRT1 pathway, a key mechanism responsible for tissue regeneration, blood vessel formation, and inflammation control.

The multidisciplinary project brought together scientists specialising in biotechnology, pharmacology, biochemistry, and medical sciences.

Exploring a plant-based alternative, the researchers found that Sinapic acid stimulates tissue repair, reduces inflammation, and promotes angiogenesis. Interestingly, a lower dose (20 mg/kg) proved more effective than a higher one, a finding known as an “inverted dose-response” pattern, which may influence future clinical applications.

The discovery could have a transformative impact on diabetic wound management by reducing amputation risks and providing a cost-effective therapy for patients in rural regions.

Future research will focus on advancing this innovation through molecular pathway analysis, safety and toxicity studies, formulation development, and pilot clinical trials in diabetic patients to confirm efficacy and safety.

(TVBRICS)

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

spot_img